CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2019	Sep. 30, 2019
Current assets:
Cash and cash equivalents	$ 8,662,853	$ 558,988
Accounts receivable, net of allowance of $4,500 at December 31, 2019 and September 30, 2019, respectively	273,969	839,951
Inventories	82,683	142,629
Prepaid expenses and other current assets	618,077	604,740
Total current assets	9,637,582	2,146,308
Property and equipment, net	184,101	226,221
Other assets:
Deferred offering costs		109,698
Deposits	62,350	62,351
Goodwill	285,386	285,386
Intangible assets, net	702,412	734,771
Total Assets	10,871,831	3,564,735
Current liabilities:
Accounts payable and accrued liabilities	1,053,554	1,616,997
Deferred revenue	455,051	628,993
Total current liabilities	1,508,605	2,245,990
Long term accrued liabilities	659,692	621,970
Secured convertible notes payable, net of debt issuance costs	1,479,254	1,442,497
Secured convertible notes payable, recorded at fair value		102,777
Total liabilities	3,647,551	4,413,234
Commitments and contingencies
Applied DNA Sciences, Inc. Stockholders' Equity (Deficit):
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0 shares issued and outstanding as of December 31, 2019 and September 30, 2019 respectively
Common stock, par value $0.001 per share; 500,000,000 shares authorized; 3,485,399 and 1,200,399 shares issued and outstanding as of December 31, 2019 and September 30, 2019, respectively	3,485	1,200
Additional paid in capital	266,699,007	255,962,930
Accumulated deficit	(259,471,142)	(256,805,589)
Applied DNA Sciences, Inc. stockholders' equity (deficit):	7,231,350	(841,459)
Noncontrolling interest	(7,070)	(7,040)
Total equity (deficit)	7,224,280	(848,499)
Total liabilities and (deficit) equity	10,871,831	3,564,735
Series A Preferred Stock [Member]
Applied DNA Sciences, Inc. Stockholders' Equity (Deficit):
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0 shares issued and outstanding as of December 31, 2019 and September 30, 2019 respectively
Series B Preferred Stock [Member]
Applied DNA Sciences, Inc. Stockholders' Equity (Deficit):
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0 shares issued and outstanding as of December 31, 2019 and September 30, 2019 respectively